HMGA2 and malignant colon neoplasm: Irinotecan is widely used in clinical practice, in particular to treat colon cancer patients [38], and we next asked whether expression of HMGA2 affected chemosensitivity to irinotecan in patient-derived xenograft (PDX) models of colorectal cancers.